Article Details

Xencor : Presents Updated Data from the Phase 1 Study of Vibecotamab in Acute Myeloid ...

Retrieved on: 2020-12-06 21:56:15

Tags for this article:

Click the tags to see associated articles and topics

Xencor : Presents Updated Data from the Phase 1 Study of Vibecotamab in Acute Myeloid .... View article details on hiswai:

Excerpt

... company developing engineered <b>monoclonal antibodies</b> for the treatment ... Vibecotamab (XmAb<sup>®</sup>14045) is a tumor-targeted antibody that contains ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up